Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / OrganismsTools
SugarDrawer
GlycanBuilder
Glycan Converters
GlycoMaple
GlycomeAtlas
LM-GlycomeAtlas
GALAXY
MCAW
GlycoSim
GRable
Guidelines
MIRAGE
G27025MB
Summary
- GlyTouCan ID
-
G27025MB
- IUPAC Condensed
- GalNAc(?1-
3D Structures
GlycoShape
Organisms
| Organisms | Evidence |
|---|---|
| Chlorocebus aethiops (grivet) | |
| Homo sapiens (human) | |
| Rhinella arenarum (Argentine toad) | |
| Cricetulus griseus (Chinese hamster) |
Taxonomic Hierarchy
Pathway
| Pathway Name | Organism |
|---|---|
| CS/DS degradation | Mus musculus |
| Glycosphingolipid catabolism | Canis familiaris |
| Glycosphingolipid catabolism | Xenopus tropicalis |
| Glycosphingolipid catabolism | Caenorhabditis elegans |
| Glycosphingolipid catabolism | Bos taurus |
| Glycosphingolipid catabolism | Dictyostelium discoideum |
| Glycosphingolipid catabolism | Gallus gallus |
| Glycosphingolipid catabolism | Homo sapiens |
| Glycosphingolipid catabolism | Rattus norvegicus |
| Glycosphingolipid catabolism | Drosophila melanogaster |
Sequence Descriptors
- GlycoCT
-
RES 1b:x-dgal-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
- WURCS
- WURCS=2.0/1,1,0/[a2112h-1x_1-5_2*NCC/3=O]/1/
Literature
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 38623423 | Bioactive carbohydrate polymers from marine sources as potent nutraceuticals in modulating obesity: a review | Geetha V | 2024 Mar 08 |
|
| 38448631 | Supplementing Glucose Intake Reverses the Inflammation Induced by a High-Fat Diet by Increasing the Expression of Siglec-E Ligands on Erythrocytes | Liu H | 2024 Mar 07 |
|
| 38204163 | Application of improved GalNAc conjugation in development of cost-effective siRNA therapies targeting cardiovascular diseases | Li Q | 2024 Mar 06 |
|
| 38441801 | Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 American Heart Association Scientific Sessions | Hermel M | 2024 Mar 05 |
|
| 38429691 | Engineering Escherichia coli for increased Und-P availability leads to material improvements in glycan expression technology | Kay EJ | 2024 Mar 01 |
|
| 38427309 | Examining the association between serum galactose-deficient IgA1 and primary IgA nephropathy: a systematic review and meta-analysis | Vaz de Castro PAS | 2024 Mar 01 |
|
| 38438619 | A thicker skin for better immune evasion | Schmidt EN | 2024 Mar |
|
| 38942968 | Potent and specific antibiotic combination therapy against Clostridioides difficile | Chioti VT | 2024 Jun 28 |
|
| 38937673 | Investigating diversity and similarity between CBM13 modules and ricin-B lectin domains using sequence similarity networks | De Coninck T | 2024 Jun 27 |
|
| 38910165 | Targeted protein degradation combined with PET imaging reveals the role of host PD-L1 in determining anti-PD-1 therapy efficacy | Du J | 2024 Jun 24 |
|
